ADIA is the peak business organisation representing manufacturers and suppliers of dental products. Our vision is for an industry that empowers oral health professionals to advance the health and wellbeing of all Australians...................... — ADIA Strategic Plan


For Manufacturers — ADIA New Exporters Grant

The Australian Dental Industry Association (ADIA) has long supported business that manufacture innovative dental products. To support those businesses to reach new overseas markets, ADIA funds the ADIA New Exporter's Grant.

The ADIA New Exporter's Grant is all about assisting first-time manufacturers to better understand the global market for dental products. The grant’s primary focus is to allow businesses to reach out to new distributors in key markets by attending the IDS Cologne dental exhibition.

There is no better platform to meet potential distributors than the IDS Cologne dental exhibition when, every two years, more than 2,000 exhibitors from more than fifty countries gather along with more than 150,000 stakeholders from across the dental community.

The ADIA New Exporter's Grant provides financial assistance of $7,500 (GST Excl.) for a business to attend the IDS Cologne dental exhibition for the first time.

2018 ADIA New Exporter's Grant —

The winner of the 2018 ADIA New Exporter's Grant is Osteon Medical. For more information please visit:

Winner of the ADIA New Exporter's Grant Announced

With a focus on supporting first-time exporters, the ADIA New Exporter's Grant will be of great assistance to those businesses with market-ready products.

Grant Eligibility Criteria –

The business must have been an ADIA member for a minimum of two years prior to applying for the grant.
The business must have an export-ready product (i.e. has market approval within Australia).
The majority of product research, development and commercialisation should be undertaken within Australia. If manufacturing is undertaken off-shore, the intellectual property should be retained within Australia.
The grant does not extend to services (e.g. consulting) but does include technical innovations such as software.
The business must not have previously attended IDS Cologne.

Networking is one of the biggest benefits of attending the IDS Cologne dental exhibition. The ADIA New Exporter's Grant will let you build relationships in person, and trade shows provide a great way to meet new people and catch up with those you already know. You’ll have the opportunity to meet new customers or business partners and strengthen relationships with other manufacturers and exporters that face the same challenges as you.

Member Engagement —

ADIA provides leadership, strategy, advocacy, and support. Our members set our agenda, fund our activities, and directly benefit from the results. With respect to the Association's work to support Australian manufacturers looking to develop new export markets, the team in the ADIA national office receive advice and guidance from members serving on the ADIA-MIG Manufacturers' Interest Group and updates are provided at the quarterly ADIA State Branch Briefings.

Further Information —

To keep up to date with how ADIA is working to support businesses the develop, commercialise and manufacture dental products subscribe to the Twitter feed @AusDental or follow us on Facebook at Alternatively, you can contact the Association via email at or by telephone on 1300 943 094.

This information is available for your use under a Creative Commons Attribution 3.0 Australia licence, with the exception of the ADIA logo, other images and where otherwise stated.

A.. A D I A . .S T R A T G E G I C . .A L L I A N C E S


Dental Industry News

  • SME Payments – Dental industry views sought

    22nd Nov 18

    The ASBFEO has invited the dental industry to provide advice that will guide a new Australian Government framework that will ensure that small and medium sized enterprises get paid on time. More

  • New Code Protects Professional Independence

    5th Jan 18

    Ensuring that decisions taken by dental professionals on patient diagnostic and treatment options are independent of undue influence by product suppliers is what underpins the industry's new code of practice. More